Lung Cancer News
Detecting Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients
Non-small cell lung cancer is the most prevalent form of lung cancer and accounts for more than 80% of all lung cancer cases. Circulating tumor cells (CTCs) [...]
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United [...]
Lung Cancer Myth Busting: Long Term Use of Face Mask Cause Lung Cancer
The health officials all around the world encourage people to wear masks to slow down the spread of COVID 19 but according to a Facebook post, it claims that [...]
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for [...]
Amgen Drug, Sotorasib, Shows Success in Phase II Trial against Non-Small Cell Lung Cancer
An Amgen Inc. lung cancer drug, sotorasib, targets an aggressive genetic mutation called KRAS. In the Phase II trial, this drug has shown to provide durable [...]
Study Shows Women Have Lower Risk of Death after Lung Cancer Surgery
The survival rates among men and women with lung cancer vary. Researchers at Karolinska Institutet in Sweden have conducted a study to find out the potential [...]
ACCC Releases Lung Cancer Care Quality Improvement Model
Lung Cancer is the second most common form of cancer among both men and women. Non-small cell lung cancer accounts for about 84% of lung cancer while small [...]
Advances in Lung Cancer Treatment Reduce Death Rates
The leading cause of death in the United States remains lung cancer. The American Cancer Society estimates that almost 230,000 new lung cancer cases will be [...]
New EarlyCDT-Lung Blood Test for Early Detection of Lung Cancer
Thanks to the pioneering new blood test, lung cancer could be detected earlier. This news comes as a fresh hope for lung cancer patients. The main reason [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Non-Smokers with COPD are at High Risk of Getting Lung Cancer
The most prominent factor behind getting lung cancer is smoking. In addition to smokers, non-smokers are also getting affected by this deadly disease. [...]
Record-Setting Drop in US Cancer Death Rate in a Single Year
According to the latest report from the American Cancer Society, the cancer death rate in US has dropped 2.2% from 2016 to 2017. This is the largest [...]